CANFNYSE Israel
Market cap
$7.370 M
$3.44 -3.37%
Close of 7 Aug 2026
Revenue
$405.0K
#3565 by revenue
Earnings
-$9.83M
Loss-making
Shares outstanding
2,618,425
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Can-Fite BioPharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.